ALK and ovarian cancer: In the same line, another interesting study, which was published during the time of the revision of our present manuscript, reported the elimination of dormant, autophagic and drug-resistant ovarian cancer cells upon crizotinib or other ALK inhibitors treatment through the potentiation of autophagy and subsequent increase in apoptosis [97].